Human Papillomavirus (HPV) Vaccination and Control

Cervical cancer incidence in Los Angeles County is significantly higher than the national average, with highest rates among Latinas and Asian/Pacific Islanders. The discovery of HPV as the primary causal agent in cervical cancer and subsequent development of HPV vaccines have revolutionized the potential for cervical cancer prevention. However, vaccine utilization rates in the US remain unacceptably low among age-eligible girls, including among […]

To combat the low rates of vaccination amongst college students, the UCLA Center for Cancer Prevention and Control Research in partnership with the Research Well pod of the Healthy Campus Initiative is conducting a study to investigate current HPV-related activities on campus and promising and feasible strategies to increase access to and use of HPV […]

The aim of this bi-national study was to compare and contrast the knowledge, beliefs, and practices regarding human papillomavirus (HPV) vaccination among mothers of vaccine-eligible girls, health care providers, and program administrators at two community clinics in Oxnard, California, and two Mexican Social Security Institute (IMSS) clinics in Cuernavaca, Mexico. Although mothers in the US had […]

In this study, the research team is comparing three ways to increase the number of youth who get the HPV vaccine. One way is to send reminders to parents to have their child vaccinated. Another way is for clinics to provide specialized training for clinicians, such as doctors and nurses, and staff to make sure […]